MARKET

BMY

BMY

Bristol-Myers Squibb Co
NYSE
57.54
-0.43
-0.74%
After Hours: 57.56 +0.02 +0.03% 18:21 07/08 EDT
OPEN
57.89
PREV CLOSE
57.97
HIGH
58.19
LOW
57.34
VOLUME
8.00M
TURNOVER
--
52 WEEK HIGH
61.55
52 WEEK LOW
40.99
MARKET CAP
117.50B
P/E (TTM)
16.15
1D
5D
1M
3M
1Y
5Y
1D
2 Dirt Cheap Dividend Stocks to Buy With $1,000 Right Now
The Motley Fool · 23h ago
2 Healthcare Stocks to Buy for Their Dividends -- and Why Pfizer Isn't One of Them
Barron‘s · 1d ago
3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)
The Motley Fool · 1d ago
SBIO: Biotech Breakthrough Opportunities Screened For Cash Burn
Seeking Alpha · 1d ago
My Top 5 Pharma Stocks Wall Street Ignores
Seeking Alpha · 2d ago
Bristol-Myers Squibb Price Target Maintained With a $54.00/Share by Cantor Fitzgerald
Dow Jones · 2d ago
Cantor Fitzgerald Reiterates Neutral on Bristol-Myers Squibb, Maintains $54 Price Target
Benzinga · 2d ago
Weekly Report: what happened at BMY last week (0629-0703)?
Weekly Report · 2d ago
More
About BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. It is engaged in the discovery, development, and delivery of transformational medicines for patients facing serious diseases in areas: oncology, hematology, immunology, cardiovascular, neuroscience and other areas. Its growth portfolio includes Opdivo (nivolumab), Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), Orencia (abatacept), Yervoy (ipilimumab), Reblozyl (luspatercept-aamt), Breyanzi (lisocabtagene maraleucel), Opdualag (nivolumab and relatlimab-rmbw), Camzyos (mavacamten), Zeposia (ozanimod), Abecma (idecabtagene vicleucel), Sotyktu (deucravacitinib), Krazati (adagrasib), and Cobenfy (xanomeline and trospium chloride). Its other growth products include Augtyro, Onureg, Inrebic, Nulojix, and Empliciti. Its legacy portfolio includes Eliquis (apixaban), Revlimid (lenalidomide), Pomalyst/Imnovid (pomalidomide), Sprycel (dasatinib), and Abraxane (paclitaxel albumin-bound particles for injectable suspension).

Webull offers Bristol-Myers Squibb Co stock information, including NYSE: BMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BMY stock methods without spending real money on the virtual paper trading platform.